Gain Therapeutics GANX
NASDAQ GANX
$1.25 -0.03 (-2.70%)
As of: Oct 23, 2026 · 3:59 PM EDT

Gain Therapeutics (GANX) Net Preferred Shares Issued and Repurchased (2020 - 2021)

Updated

Gain Therapeutics' Net Preferred Shares Issued and Repurchased was $9.9 million in Q1 2021, up 793.4% from $1.11 million a year earlier.

Analysis

Gain Therapeutics (GANX) Net Preferred Shares Issued and Repurchased (2020 - 2021) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Pref. Shares Issued (Qtr)
1 Eli Lilly 1,137.66 Bn 1,106.24 Bn 19.71 Bn -
2 Johnson & Johnson 636.13 Bn 556.00 Bn 17.30 Bn -
3 AbbVie 505.28 Bn 478.39 Bn 12.70 Bn -
4 Merck 358.10 Bn 312.48 Bn 12.21 Bn -
5 Novartis Ag 292.59 Bn 256.58 Bn 11.24 Bn -
6 Astrazeneca 265.81 Bn 239.50 Bn 12.86 Bn -
7 Amgen 237.53 Bn 192.93 Bn 7.24 Bn -
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn -
9 Pfizer 171.17 Bn 117.82 Bn 10.94 Bn -
10 Gain Therapeutics 54.24 Mn -5.04 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2021 9.90 Mn
Jun 30, 2020 -10,554.00
Mar 31, 2020 1.11 Mn
API Access

Gain Therapeutics Net Preferred Shares Issued and Repurchased API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-preferred-shares-issued-and-repurchased&ticker=GANX&period=max&api_key=YOUR_API_KEY